145 related articles for article (PubMed ID: 1668786)
1. Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas.
Sunday ME; Choi N; Spindel ER; Chin WW; Mark EJ
Hum Pathol; 1991 Oct; 22(10):1030-9. PubMed ID: 1668786
[TBL] [Abstract][Full Text] [Related]
2. Correlative immunohistochemical and reverse transcriptase polymerase chain reaction analysis of somatostatin receptor type 2 in neuroendocrine tumors of the lung.
Papotti M; Croce S; Macrì L; Funaro A; Pecchioni C; Schindler M; Bussolati G
Diagn Mol Pathol; 2000 Mar; 9(1):47-57. PubMed ID: 10718213
[TBL] [Abstract][Full Text] [Related]
3. Gastrin-releasing peptide, a mammalian analog of bombesin, is present in human neuroendocrine lung tumors.
Bostwick DG; Roth KA; Evans CJ; Barchas JD; Bensch KG
Am J Pathol; 1984 Nov; 117(2):195-200. PubMed ID: 6093543
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
Nisman B; Heching N; Biran H; Barak V; Peretz T
Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical markers of small cell carcinoma and related neuroendocrine tumours of the lung.
Addis BJ; Hamid Q; Ibrahim NB; Fahey M; Bloom SR; Polak JM
J Pathol; 1987 Oct; 153(2):137-50. PubMed ID: 2826741
[TBL] [Abstract][Full Text] [Related]
6. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.
Jiang SX; Kameya T; Asamura H; Umezawa A; Sato Y; Shinada J; Kawakubo Y; Igarashi T; Nagai K; Okayasu I
Mod Pathol; 2004 Feb; 17(2):222-9. PubMed ID: 14657947
[TBL] [Abstract][Full Text] [Related]
7. NSP-encoded reticulons are neuroendocrine markers of a novel category in human lung cancer diagnosis.
van de Velde HJ; Senden NH; Roskams TA; Broers JL; Ramaekers FC; Roebroek AJ; Van de Ven WJ
Cancer Res; 1994 Sep; 54(17):4769-76. PubMed ID: 8062278
[TBL] [Abstract][Full Text] [Related]
8. Pro-gastrin-releasing peptide (ProGRP)--a useful marker in small cell lung carcinomas.
Stieber P; Dienemann H; Schalhorn A; Schmitt UM; Reinmiedl J; Hofmann K; Yamaguchi K
Anticancer Res; 1999; 19(4A):2673-8. PubMed ID: 10470218
[TBL] [Abstract][Full Text] [Related]
9. GRP receptors are present in non small cell lung cancer cells.
Moody TW; Zia F; Venugopal R; Fagarasan M; Oie H; Hu V
J Cell Biochem Suppl; 1996; 24():247-56. PubMed ID: 8806107
[TBL] [Abstract][Full Text] [Related]
10. Expression of gastrin-releasing peptide (human bombesin) gene in large cell undifferentiated carcinoma of the lung.
Hamid QA; Corrin B; Dewar A; Hoefler H; Sheppard MN
J Pathol; 1990 Jun; 161(2):145-51. PubMed ID: 2166149
[TBL] [Abstract][Full Text] [Related]
11. Gastrin releasing peptide in human neuroendocrine tumours.
Bostwick DG; Bensch KG
J Pathol; 1985 Dec; 147(4):237-44. PubMed ID: 3003308
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical studies on gastrin-releasing peptide- and adrenocorticotropic hormone-containing cells in the human lung.
Tsutsumi Y; Osamura RY; Watanabe K; Yanaihara N
Lab Invest; 1983 May; 48(5):623-32. PubMed ID: 6188883
[TBL] [Abstract][Full Text] [Related]
13. Expression of the vasopressin and gastrin-releasing peptide genes in small cell lung carcinoma cell lines.
Verbeeck MA; Elands JP; de Leij LF; Buys CH; Carney DN; Bepler G; Roebroeck AJ; Van de Ven WJ; Burbach JP
Pathobiology; 1992; 60(3):136-42. PubMed ID: 1320893
[TBL] [Abstract][Full Text] [Related]
14. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
15. Production and molecular size heterogeneity of immunoreactive gastrin-releasing peptide in fetal and adult lungs and primary lung tumors.
Yamaguchi K; Abe K; Kameya T; Adachi I; Taguchi S; Otsubo K; Yanaihara N
Cancer Res; 1983 Aug; 43(8):3932-9. PubMed ID: 6861155
[TBL] [Abstract][Full Text] [Related]
16. Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations.
Loy TS; Darkow GV; Quesenberry JT
Am J Surg Pathol; 1995 Feb; 19(2):173-82. PubMed ID: 7832277
[TBL] [Abstract][Full Text] [Related]
17. Gastrin-releasing peptide immunoreactivity in intestinal carcinoids.
Bostwick DG; Roth KA; Barchas JD; Bensch KG
Am J Clin Pathol; 1984 Oct; 82(4):428-31. PubMed ID: 6475838
[TBL] [Abstract][Full Text] [Related]
18. Molecular markers for reinforcement of histological subclassification of neuroendocrine lung tumors.
Kobayashi Y; Tokuchi Y; Hashimoto T; Hayashi M; Nishimura H; Ishikawa Y; Nakagawa K; Sato Y; Takahashi A; Tsuchiya E
Cancer Sci; 2004 Apr; 95(4):334-41. PubMed ID: 15072592
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2, p53, CD44, and CD44v6 isoform expression in neuroendocrine tumors of the lung.
Coppola D; Clarke M; Landreneau R; Weyant RJ; Cooper D; Yousem SA
Mod Pathol; 1996 May; 9(5):484-90. PubMed ID: 8733762
[TBL] [Abstract][Full Text] [Related]
20. Immunocytologic diagnosis of small-cell lung cancer in imprint smears.
Tome Y; Hirohashi S; Noguchi M; Matsuno Y; Kishi K; Uei Y; Shimosato Y
Acta Cytol; 1991; 35(5):485-90. PubMed ID: 1656682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
